TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities
International Journal of Molecular Sciences · 05.07.2024 · 25 (13) · 7400
DOI: 10.3390/ijms25137400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.07.2024. Verfasst von Morena Fasano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Transforming Growth Factor beta, Signal Transduction, Tumor Microenvironment. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide, with 20% of patients presenting with metastatic disease at diagnosis. TGF-β signaling plays a crucial role in various cellular processes, including growth, differentiation, apoptosis, epithelial-mesenchymal transition (EMT), regulation of the extracellular matrix, angiogenesis, and immune responses. TGF-β signals through SMAD proteins, which are intracellular molecules that transmit TGF-β signals from the cell membrane to the nucleus. Alterations in the TGF-β pathway and mutations in SMAD proteins are common in metastatic CRC (mCRC), making them critical factors in CRC tumorigenesis. This review first analyzes normal TGF-β signaling and then investigates its role in CRC pathogenesis, highlighting the mechanisms through which TGF-β influences metastasis development. TGF-β promotes neoangiogenesis via VEGF overexpression, pericyte differentiation, and other mechanisms. Additionally, TGF-β affects various elements of the tumor microenvironment, including T cells, fibroblasts, and macrophages, promoting immunosuppression and metastasis. Given its strategic role in multiple processes, we explored different strategies to target TGF-β in mCRC patients, aiming to identify new therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy.
- Department of Precision Medicine, University of Campania "L. Vanvitelli", 80138 Naples, Italy.
- Laboratory of Precision and Molecular Oncology, Biogem Scarl, Institute of Genetic Research, Contrada Camporeale, 83031 Ariano Irpino, Italy.
- Oncology Operative Unit, Hospital of Frattamaggiore, ASLNA2NORD, Frattamaggiore, 80027 Naples, Italy.
ORCID-Profile: Morena Fasano, Michele Caraglia, Mariarosaria Boccellino, Raffaele Addeo
Zitieren
APA
Fasano, M., Pirozzi, M., Miceli, C. C., Cocule, M., Caraglia, M., Boccellino, M., Vitale, P., De Falco, V., Farese, S., Zotta, A., Ciardiello, F., & Addeo, R. (2024). TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities. International Journal of Molecular Sciences, 25(13), 7400. https://doi.org/10.3390/ijms25137400
Vancouver
Fasano M, Pirozzi M, Miceli CC, Cocule M, Caraglia M, Boccellino M, et al. TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities. International Journal of Molecular Sciences. 2024;25(13):7400. doi:10.3390/ijms25137400
BibTeX
@article{Fasano2024,
author = {Fasano, Morena and Pirozzi, Mario and Miceli, Chiara Carmen and Cocule, Mariateresa and Caraglia, Michele and Boccellino, Mariarosaria and Vitale, Pasquale and De Falco, Vincenzo and Farese, Stefano and Zotta, Alessia and Ciardiello, Fortunato and Addeo, Raffaele},
title = {TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7400},
doi = {10.3390/ijms25137400}
}
EUVIMED